InvestorsHub Logo
Followers 0
Posts 142
Boards Moderated 0
Alias Born 05/20/2016

Re: tonecee post# 15473

Thursday, 06/22/2017 7:19:29 AM

Thursday, June 22, 2017 7:19:29 AM

Post# of 233035
• CytoDyn (OTCQB:CYDY) reports that, on June 19 and 20, it issued $1.7M aggregate principal amount of unsecured convertible promissory notes to accredited investors.
• The notes bear annual interest of 7.0% and are convertible into common shares at any time at $0.75 per share (total of 2,266,665 shares). Investors also received five-year warrants to purchase up to 1,133,332 shares of common at $1.00 per share.
• The placement agent received five-year warrants to purchase 8% of the number of shares underlying the notes at $0.825 per share and a cash fee equal to 9% of the gross proceeds received by the company in addition to other consideration.
• Proceeds will fund working capital and clinical trials.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News